A drug to treat malaria - the first such pill to get approval in 60 years - has been given the green light by authorities in the United States. The medicine is specifically for the recurring form ...

The European Commission has granted marketing authorization for Gilead Sciences' twice-yearly injection for preventing HIV infection, the company said on Tuesday. The drug, known scientifically as ...

Until now, malaria treatments have only been tested in children at least 6 months old, and no drug had been an approved malaria treatment for infants under 9.9 pounds (4.5 kilograms).

The mosquito-borne illness is the deadliest disease in Africa, whose 1.5 billion people accounted for 95% of an estimated 597,000 malaria deaths worldwide in 2023, according to WHO.

The mosquito-borne illness is the deadliest disease in Africa, whose 1.5 billion people accounted for 95% of an estimated 597,000 malaria deaths worldwide in 2023, according to WHO.

Drug resistance In October 2017, the WHO Malaria Policy Advisory Committee highlighted the need for alternative medicines to prevent malaria in pregnant women living with HIV because of increasing ...

The private market for malaria treatment is Africa is about 15 million to 20 million treatments a year. About 45 companies supply it, Jansen said, with Dafra having about a 25 percent share.

The approval of the first malaria treatment for newborns and young infants could lead to imminent widespread use in Africa, drugmaker Novartis said Tuesday. The drug, known as Coartem Baby or ...

STEVE INSKEEP, HOST: An anti-malaria drug that has saved millions of lives may be losing its effectiveness. In Africa, where many children are at risk, medical professionals are worried.

Generic Name: Artemether + Lumefantrine 20/120mg Dispersible Tablet. Batch No: 7225119. NAFDAC Reg No: A11-0299. Manufacturing Date: June 2023 and Feb 2023. Expiry Date: May 2026 and June 2026.

A new approach to predicting malaria drug resistance Study of malaria parasite genomes paves the way for new, more effective treatments Date: December 9, 2024 Source: University of California ...